Algert Global LLC Unity Biotechnology, Inc. Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.72 - $1.86 $29,031 - $74,998	-40,322 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.3 - $3.17 $10,283 - $25,074	7,910 Added 24.4%	40,322 $59,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.5 $94,318 - $145,854	32,412 New	32,412 $97,000
Q1 2021 May 14, 2021	SELL	$5.51 - $9.42 $285,913 - $488,803	-51,890 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $152,556 - $644,992	51,890 New	51,890 $180,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.